- The treatment of Graves' disease in children and adolescents
-
Lee HS, Hwang JS
- KMID: 2134078
- Ann Pediatr Endocrinol Metab.
- 2014 Sep;19(3):122-126.
- doi: 10.6065/apem.2014.19.3.122
Graves' disease (GD) accounts for 10%-15% of thyroid disorders in children and adolescents. The use of antithyroid drugs as the initial treatment option in GD is well accepted. An average... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of thyrotoxic periodic paralysis as initial manifestation of Graves' disease in a 16-year-old Korean adolescent
-
Jung SY, Song KC, Shin JI, Chae HW, Kim HS, Kwon AR
- KMID: 2134086
- Ann Pediatr Endocrinol Metab.
- 2014 Sep;19(3):169-173.
- doi: 10.6065/apem.2014.19.3.169
Thyrotoxic periodic paralysis (TPP) is a rare complication of hyperthyroidism, with recurrent muscle paralysis and hypokalemia that are caused by an intracellular shift of potassium. TPP is relatively common in... -
- CITED
-
- Close
- SHARE
-
- Close
- A 3-year-old girl with Graves' disease with literature review
-
Ho YH, Chung EC, Park SA
- KMID: 2134083
- Ann Pediatr Endocrinol Metab.
- 2014 Sep;19(3):154-158.
- doi: 10.6065/apem.2014.19.3.154
Graves' disease, the main cause of hyperthyroidism in the pediatric age group, is very rare in children younger than 4 years old but can seriously interfere with growth and development... -
- CITED
-
- Close
- SHARE
-
- Close
- Prepubertal unilateral gynecomastia in the absence of endocrine abnormalities
-
Kang M, Lee CJ, Hwang IT, Lee K, Kang MJ
- KMID: 2134084
- Ann Pediatr Endocrinol Metab.
- 2014 Sep;19(3):159-163.
- doi: 10.6065/apem.2014.19.3.159
Gynecomastia is defined as the excessive development of breast tissue in males, which can occur as unilateral or bilateral. Although the overall prevalence of gynecomastia is 40%-65%, the prepubertal unilateral... -
- CITED
-
- Close
- SHARE
-
- Close
- Neonatal screening and a new cause of congenital central hypothyroidism
-
Tajima T, Nakamura A, Morikawa S, Ishizu K
- KMID: 2134077
- Ann Pediatr Endocrinol Metab.
- 2014 Sep;19(3):117-121.
- doi: 10.6065/apem.2014.19.3.117
Congenital central hypothyroidism (C-CH) is a rare disease in which thyroid hormone deficiency is caused by insufficient thyrotropin (TSH) stimulation of a normally-located thyroid gland. Most patients with C-CH have... -
- CITED
-
- Close
- SHARE
-
- Close
- Earlier re-evaluation may be possible in pediatric patients with eutopic congenital hypothyroidism requiring lower L-thyroxine doses
-
Cho MS, Cho GS, Park SH, Jung MH, Suh BK, Koh DG
- KMID: 2134081
- Ann Pediatr Endocrinol Metab.
- 2014 Sep;19(3):141-145.
- doi: 10.6065/apem.2014.19.3.141
PURPOSE: The incidence of congenital hypothyroidism (CH) has increased in several countries. Lower cut-off in screening programs have led to an increase in the proportion of transient hypothyroidism (TH) cases... -
- CITED
-
- Close
- SHARE
-
- Close
- New Korean reference for birth weight by gestational age and sex: data from the Korean Statistical Information Service (2008-2012)
-
Lim JS, Lim SW, Ahn JH, Song BS, Shim KS, Hwang IT
- KMID: 2134082
- Ann Pediatr Endocrinol Metab.
- 2014 Sep;19(3):146-153.
- doi: 10.6065/apem.2014.19.3.146
PURPOSE: To construct new Korean reference curves for birth weight by sex and gestational age using contemporary Korean birth weight data and to compare them with the Lubchenco and the... -
- CITED
-
- Close
- SHARE
-
- Close
- No influence of parental origin of intact X chromosome and/or Y chromosome sequences on three-year height response to growth hormone therapy in Turner syndrome
-
Lee HJ, Jung HW, Lee GM, Kim HY, Kim JH, Lee SH, Kim JH, Lee YA, Shin CH, Yang SW
- KMID: 2134079
- Ann Pediatr Endocrinol Metab.
- 2014 Sep;19(3):127-134.
- doi: 10.6065/apem.2014.19.3.127
PURPOSE: Whether parental origin of the intact X chromosome and/or the presence of Y chromosome sequences (Yseq) play a role in three-year height response to growth hormone (GH) were investigated. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term follow-up on Cushing disease patient after transsphenoidal surgery
-
Jeong I, Oh M, Kim JH, Cho JH, Choi JH, Yoo HW
- KMID: 2134085
- Ann Pediatr Endocrinol Metab.
- 2014 Sep;19(3):164-168.
- doi: 10.6065/apem.2014.19.3.164
Cushing disease is caused by excessive adrenocorticotropic hormone (ACTH) production by the pituitary adenoma. Transsphenoidal surgery is its first-line treatment. The incidence of Cushing disease in children and adolescents is... -
- CITED
-
- Close
- SHARE
-
- Close
- Significant adverse reactions to long-acting gonadotropin-releasing hormone agonists for the treatment of central precocious puberty and early onset puberty
-
Lee JW, Kim HJ, Choe YM, Kang HS, Kim SK, Jun YH, Lee JE
- KMID: 2134080
- Ann Pediatr Endocrinol Metab.
- 2014 Sep;19(3):135-140.
- doi: 10.6065/apem.2014.19.3.135
PURPOSE: Long-acting gonadotropin-releasing hormone agonists (GnRHa) are commonly used to treat central precocious puberty (CPP) in Korea. Although rare, there have been reports on the characteristic of adverse reactions of... -
- CITED
-
- Close
- SHARE
-
- Close
